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Abstract
Adherence to antiretroviral therapy (ART) remains an impor-
tant factor in HIV prevention and treatment efforts. We
explored the individual and environmental factors influencing
antiretroviral adherence among PLWH in Ghana. This study
used 20 semi-structured in-depth interviews and three focus
group discussions (FGD) involving 29 PLWH attending one of
three antiretroviral clinics. Thematic analysis covered experi-
ences of PLWH clinic visits, knowledge, attitudes, self-efficacy
related to ART adherence, psychological wellbeing and stigma.
The findings suggest that both individual and environmental
factors including treatment outcome, coping skills, disclosure,
self-regulation, healthcare-provider interaction, family and
partner support, organization of ART clinics, stigma, and trans-
portation cost influenced treatment adherence. Interventions
that empower PLWH and reduce HIV-related stigma in the
community will most likely support antiretroviral adherence.
Please refer to the Supplementary Material section to find this
article's Community and Social Impact Statement.
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1 | INTRODUCTION
The availability of antiretroviral therapy (ART) for persons living with HIV (PLWH) has changed the dynamics of living with
HIV (human immunodeficiency virus) and its treatment. The “Treat All Policy” further enhances current HIV prevention, treat-
ment, and care. This policy requires that, unlike previously where CD4 (white blood cells that fights infection and an indicator
of immune function) was used as an indicator for starting antiretroviral treatment, immediately a person is tested HIV posi-
tive, this person should receive ART irrespective of the CD4 count (UNAIDS, 2019). In Ghana, an estimated 342,307 people
were living with HIV in 2019 out of a population of about 31,072,940 with an HIV prevalence of 1.7 and 46% were on ART
(Ghana AIDS Commission, 2020). The National Strategic Framework (2016–2021) seeks to ensure that by the year 2020;
90% of all PLWH know their HIV status; 90% of all people diagnosed with HIV infection receive sustained ART; and 90% of
all receiving ART will have viral suppression. Ghana is currently using triple therapy for HIV treatment. The recommended
triple-therapy regimens are two nucleoside/tide reverse transcriptase inhibitors (NRTIs) and one non-nucleoside reverse tran-
scriptase inhibitor or 2 NRTIs and 1 boosted Protease Inhibitor (Ghana AIDS Commission, 2020).
Adherence to ART reduces disease progression and drug resistance (Lucas, Chaisson, & Moore, 1999), increases life
expectancy, reduces HIV transmissibility, as well as well-being among PLWH (Teeraananchai, Kerr, Amin, Ruxrungtham, &
Law, 2017). Adherence is the “extent to which patients take medications as prescribed by their health care providers”
(Osterberg & Blaschke, 2005). The primary elements of adherence are starting a recommended regimen, completing the
prescribed regimen, and staying on the medication for the length of time allotted before discontinuation.
A meta-analysis of ART adherence studies conducted in sub-Saharan Africa estimated an adherence rate of 77%,
which is below the optimal adherence of 95–100% (Mills et al., 2006). Studies in Tanzania and Eastern Ethiopia estimated
adherence of 63.7 and 85.6%, respectively (Achappa et al., 2013; Jima & Tatiparthi, 2018), while some studies in Ghana
reported an ART adherence of 60 to 80% (Obirikorang, Selleh, Abledu, & Fofie, 2013; Ohene & Forson, 2009). A compar-
ative analysis of adherence in some African and Asian countries reported adherence of 92.7 to 95.2%, respectively (Bijker
et al., 2017). Sub-optimal adherence (i.e., adherence below 95%) is associated with a change from the standard treatment
to more expensive treatment options and an increased likelihood of treatment failures (Ickovics et al., 2002).
To intervene on sub-optimal adherence, it is necessary to understand what factors influence correct and consistent
adherence to ART among PLWH. The socio-ecological model recognizes that the factors influencing health behaviour
span through individual, interpersonal, community, and societal levels (Williams, Renju, Ghilardi, & Wringe, 2017).
Individual factors including socio-demographic (Croome, Ahluwalia, Hughes, & Abas, 2017) as well as psychosocial fac-
tors are shown to influence ART adherence (Shubber et al., 2016). Religion is a facilitator when the belief in a deity serves
as a coping strategy for medication uptake; nevertheless, it becomes a barrier when the belief informs PLWH decision to
reject medication, for example, PLWH who turn to believe in deity's power to cure infection may refuse to take ART
(Kretchy, Owusu-Daaku, & Danquah, 2013). Self-efficacy influences the adherence behaviour of PLWH in that when a
patient has low self-efficacy, (s) he may doubt her/his confidence to adhere to medication towards viral suppression. Those
with low self-efficacy are also more likely to hide their HIV status (Dima, Schweitzer, Diaconiţ, Remor, &Wanless, 2013).
In addition, PLWH who is not satisfied with his/her treatment are likely to make individual decisions not to adhere to
medication without consulting their health care provider. The fear of stigmatization, mistreatment at work, and social circles
reinforces concealment of HIV status and affects medication adherence. This is because PLWH will have to ensure secrecy
when taking medication, which is not always possible (Azia, Mukumbang, & Van Wyk, 2016). When PLWH are under the
constant fear of being identified as HIV patients, they are likely to be depressed and anxious (Shubber et al., 2016). Psycho-
logical distress can have a toll on their quality of life and medication adherence (Bijker et al., 2017). Additionally, when PLWH
has insufficient access to safe and nutritionally adequate food, which is essential for the body to respond to ART, medication
intake, and adherence may be compromised. Health-behavioural theories (Ajzen, 1991; Bandura, 1977; Rosenstock, 1977)
support these individual factors in explaining treatment non-adherence. Interpersonal factors were also reported as barriers to
ART adherence (Heestermans, Browne, Aitken, Vervoort, & Klipstein-Grobusch, 2016). Often PLWH decides not to disclose
their HIV status to their partners or family members for fear of their negative reactions such as verbal abuse and abandon-
ment. The decision not to disclose their HIV status undermines the support they could get from their family members or
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partners (Adeniyi et al., 2018). Social support, which refers to the psychological and tangible resources PLWH receives from
their social network (Cohen & Wills, 1985), is relevant to the overall well-being of PLWH. This support reduces depression
(Tsai et al., 2012), improves medication adherence, coping, and quality of life of PLWH (Katz et al., 2013).
Globally, community factors related to ART adherence are mostly ART facility-related factors (Shubber et al., 2016).
The healthcare provider may be the only one who knows the HIV status of PLWH. As such, the relationship between the
healthcare provider and the patient is crucial to the patient antiretroviral adherence. A patient who enjoys a good rela-
tionship with health care providers has better adherence and vice versa (Mwamba et al., 2018). PLWH who keep their
clinic appointments are likely to adhere to medication. In resource-constrained settings, this comes at a cost to the
patient: cost of transport, cost of foregoing daily income-generating activities, and some unexpected cost at the clinic.
When PLWH is not in the position to manage these costs, they will miss their appointments for a refill.
Within all the levels of the ecological model, HIV-related stigma plays a role, thus affecting medication adher-
ence (Dovidio, Major, & Crocker, 2000). PLWH, especially those in developing countries, often live in communities
where negative norms related to being PLWH exist. These norms could be internalized by PLWH. Community mem-
bers' perceptions of how they were infected will inform their decision to be either empathetic or aggressive towards
PLWH. These stigmatizing responses in turn influence adherence (Bos, Pryor, Reeder, & Stutterheim, 2013).
Societal factors that influence adherence are evident in laws and policies in many countries (Ferguson
et al., 2018; Health Policy Plus, 2017). Even though these factors are beyond the scope of this paper, it is worth
mentioning that the Ghana AIDS Commission Act 938 has anti-discriminatory laws for persons living with and
affected by HIV (Health Policy Plus, 2017); however, there are punitive laws for key populations which may serve as
a barrier to ART adherence (Laar & Debruin, 2017). Anecdotal evidence suggests that these restrictive laws are bar-
riers to accessing HIV care and treatment.
PLWH antiretroviral adherence is influenced by factors that may overlap but can also vary across different
regions of the world (Croome et al., 2017; Mills et al., 2006). Although the literature review shows several scientific
publications on this topic, there is limited research on the context-specific factors influencing ART adherence among
PLWH in Ghana. The available publications on treatment adherence among PLWH in Ghana so far focus on adoles-
cents (Ankrah et al., 2016; Nichols et al., 2019) and used a quantitative approach (Obirikorang et al., 2013; Ohene &
Forson, 2009) with emphasis on individual-level factors. To fill this gap, our study sought to explore the individual
and environmental factors influencing ART adherence of PLWH in the Bono East Region located in the middle belt
of Ghana using qualitative interviews and focus group discussions (FGD). A clear understanding of the perspectives
of PLWH on factors influencing medication adherence in Ghana will contribute to the literature and the develop-
ment of targeted evidence-informed interventions for optimal treatment and health outcomes.
2 | MATERIALS AND METHODS
2.1 | Study design
A qualitative semi-structured interview protocol was used to guide both in-depth individual interviews (IDI) and Focus
Group Discussions (FGD) to explore the factors influencing antiretroviral treatment adherence of PLWH. The use of a
semi-structured interview guide allowed us to adapt to the course of the conversation, respond to social cues and permit
the participants to express their opinions while maintaining consistency across the different interviews.
2.2 | Study setting and site selection
The Bono East Region is one of 16 administrative regions in Ghana. The region has 11 districts and over 40 health
facilities that provide health services to its inhabitants. HIV prevalence in this region is 1.43% (Quaicoe Rebecca &
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Maafo, 2018). Interviews were conducted in Kintampo South District, Kintampo North, and Techiman South
Municipality.
We purposively selected three ART clinics that attend to a PLWH- registered population of 4,237. Their strate-
gic locations within the region, the set-up similarities for ART clinics in Ghana, the size of the clinic, and its organiza-
tion (stand-alone vs. integrated) informed the selection of these facilities. The ART clinics are located within the
Kintampo North Municipal hospital, Kintampo South District hospital, and Holy Family Hospital, Techiman.
2.3 | Participants
In total, 49 PLWH participated in the study, 20 in IDIs and 29 in FGDs. The mean age of participants was 38.3 years
(SD = 10.3, range 23–58). The participants were mostly females (81.6%). Most participants (59.1%) had some form
of education. Near 45% of PLWH were married and 55% were unmarried. Most of the participants were Christians
(90%); the remaining 10% either were Muslims or had no religion. Of the participants 39% were farmers, 37% were
traders (yam sellers, cosmetic sellers), and 22% were unemployed. The participants in this study had been living with
HIV for 2 to 12 years.
2.4 | Study procedures
We asked adult PLWH who were queuing at the ART clinic to participate in a 30-60 min interview. If they were will-
ing, we confirmed the eligibility criteria (age 18+) and gave information about the study. The average number of
PLWH visiting these ART clinics in a week for either refills or general consultation was 20. We explained individually
to participants that the study was exploring PLWH perspectives and experiences with antiretroviral uptake and hos-
pital visits. We assured potential participants of confidentiality, the voluntariness of participation, and the right to
withdraw from the study at any point in the study.
Those who agreed consented right after their consultation and refill. Before starting the IDI/FGD, written
informed consent was obtained from each participant in advance of the IDIs and FGDs after the aim, objectives, and
procedures of the study were once more explained. A signature or thumbprint from each participant was printed on
each written informed consent with a copy on file and another copy provided to the participant who was willing to
keep a copy. In total, 23 PLWH were approached for the IDI of which 20 agreed to participate (75% female). Two
PLWH refused to participate in the IDI due to other engagements. We achieved saturation by the 18th interview;
two additional interviews were conducted after which we ended recruitment. After finishing all 20 IDIs, models of
hope (HIV+ peer models) invited PLWH to participate in FGD according to the same procedure as described above.
Models of Hope are trained PLWH who provide adherence counselling and track defaulters. They are mostly people
with lived experiences. Models have gone through the process of starting ART and understand the challenges newly
diagnosed clients face with issues related to stigma and discrimination. They are more effective in reintegrating
defaulters. Three participants from the Kintampo site were recruited via phone: because their medication was mostly
home-delivered by the models of hope. All twenty-nine approached agreed to participate in one of the three FGDs.
All IDI's were conducted within the hospital premises in an unused room that ensured the privacy of the partici-
pants. The FGDs were conducted at an unused children's clinic, a vacant reproductive health room, and a vacant
adherence counselling room. Some nuances that emerged from IDI were further explored in the FGD. The three
FGDs had six (one male, five females), six (one male, five females), and seventeen (three males, fourteen females)
PLWH, respectively. Although we recognize 17 to be a large group, we could not divide the group due to practical
issues. Nonetheless, we organized the discussion such that each participant was able to talk during the discussion.
The lead author, together with a social scientist from the Kintampo Health Research Centre, moderated
the interviews and discussions. We conducted all interviews in Twi (the local language spoken by all of the
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participants). All the participants received a bar of key soap as a thank you package for their time and volun-
tary willingness to participate in the study. Focus Group discussants in addition to the key soap received a
soft drink and a pastry after the interviews.
2.5 | Study materials
The interview protocol was semi-structured and guided by literature review and theoretical concepts
explaining factors influencing ART adherence including experiences with ART adherence and clinic visits.
The protocol was discussed with relevant stakeholders in the field of HIV prevention, care, and treatment.
The interview protocol was structured according to themes including experiences with treatment and
adherence and experiences at the ART centers. Each theme included follow-up questions for further
exploration of factors such as knowledge, attitudes, self-efficacy related to ART, psychological well-being,
and stigma.
2.6 | Data management and analysis
All digital audio recordings were transcribed verbatim and translated from the local language into English. Twenty-
five percent of the transcripts were double-checked by the lead author to confirm the translation. We checked for
the validity of the data by triangulation using IDI, FGD, and different interviewers. The transcripts were entered into
the software program Atlas Ti version 8 for analysis.
The first and the second author coded three interviews together. Any different opinions on the coding
were discussed until we reached an agreement. The first author coded the remaining interviews. The first
and the second author did all summaries together and discussed any nuances. We used inductive thematic
analysis that allows for the identification, analysis, and reporting of common themes within the qualitative
data. The use of this method allowed us to develop codes and themes based on the content of the data
(Boyatzis, 1998).
We analysed the data by carrying out open, selective, and theoretical coding at three levels: at the initial coding
level all transcripts were read to identify general themes emerging, these themes were grouped into smaller themes
at the second level. Levels one and two codes were reviewed at the third level to develop the major thematic catego-
ries. Reports were generated for each thematic category and reviewed. All quotes that did not fit the selected code
were recoded from that category into its appropriate category. Other emerging themes that were peculiar to some
transcripts were then added. The summaries for all categorized themes have been presented as results for exploring
the factors (individual and environmental) influencing antiretroviral treatment adherence of PLWH in the Bono East
Region of Ghana.
Ethical approval for the conduct of the study was obtained from the Institutional Ethics Committee (IEC) of the
Kintampo Health Research Centre (FWA00011103) and the Ethical Review Committee Psychology and Neurosci-
ence at Maastricht University (ECP_04_09_2012_S22). Permissions were received from the Medical Superintendents
of the selected hospitals to carry out interviews in their facilities.
3 | RESULTS
First, we report on the adherence behaviour of the participants. This is followed by the determinants that influence
ART adherence grouped into two categories: individual and environmental (including interpersonal and community
factors).
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3.1 | Adherence behaviour
Most of the participants had been on ART for the past 5 years at the time of data collection. Irrespective of age,
PLWH revealed that they take ART because their life depends on it. While most indicated they never skipped
their medication, a few others said they sometimes forgot to do so because they were preoccupied with
their jobs.
3.2 | Individual factors
3.2.1 | Self-regulation for ART adherence
All participants in the IDIs and FGDs indicated that they could take their medication without any difficulty. They
were able to take the medication with ease as prescribed by the health care provider. They used self-regulation strat-
egies like using a different pill bottle when travelling (to avoid stigma), or memory cues such as putting the medica-
tion in clear vision (e.g., table), incorporating it as part of their daily schedule by using wake-up and bedtimes or
breakfast and dinner times.
“No sister [it is not difficult], once we eat every day taking the medication is as easy as that”. (30-year-old
IDI participant)
3.2.2 | Outcome efficacy of ART treatment
All PLWH indicated that their condition has improved since they started taking the antiretroviral. They are optimistic
that if they continue to take antiretroviral, they will no longer die from HIV; it makes them look very healthy, stron-
ger, and able to work and therefore reduces potential HIV-related stigma. For most PLWH, the improved health sta-
tus has helped to conceal their HIV status. Altogether, IDI and FGD participants corroborate that, the fast and visible
improvement in health is one of the major drives for treatment adherence:
“Oh, the medication is very good. If I say it is not good, I would be lying. Apart from God who gives me life,
it is my God. I was not like this. I was wasted. However, upon taking the medication, I am fit…”. (28-year-
old female IDI participant)
Interestingly, one participant said even though ill health reduced she noticed that the antiretroviral made her
chronically weak and has affected her daily activities.
“Ever since I started the medication (ARV), I have never been able to go to the farm. I am chronically weak”
(32-year-old female FGD participants)
Another participant indicated that the efficacy of the antiretroviral helped him to abort any plans of committing
suicide.
“My recovery from frequent ailments after taking the antiretroviral motivated me to discard the
idea of poisoning myself. Before I started the antiretroviral, I went to the hospital severally without
recovery until my brother came from Britain and took me to the hospital” (45-year-old male IDI
participant)
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3.2.3 | Side effects of ART medication
Most participants said they had experienced side effects especially at the start of taking the antiretroviral. Some par-
ticipants mentioned side effects such as dizziness, weakness, diarrhoea, skin rashes, nightmares, palpitation, confu-
sion, and vomiting.
“I started the ARV for two weeks, when I began, my legs were swollen and oedematous, and I was bedrid-
den for 6 months. I was admitted at the hospital for 3 months to take the fluid from my thigh. It took the
intervention of both local and foreign doctors to survive…Since then I have never experienced any side
effects. For that particular antiretroviral that gave me this side effects, no matter what I will not take it”
(33-year-old female IDI participant)
Some participants said health care providers warned them about the side effects. The side effects diminished
after a while or upon complaining to the healthcare provider, they changed the medication. In general, it seems that
the side effects did not stop them from taking the medication.
3.2.4 | Knowledge about HIV and ART
Most PLWH who were knowledgeable about the causes, treatment, and management of HIV, (learned it either
through counselling, training from health facilities, or various courses related to HIV) were inclined to understanding
HIV transmission and antiretroviral intake. This seemed to help them with ART uptake.
“What helped me most was that in the same year that I was diagnosed, there was an opportunity to do a
course in HIV at the University of Ghana… This exposed me to a lot of information on HIV and I learned
many things”. (56-year-old male FGD participant)
3.2.5 | Anticipated stigma
The majority of participants in both IDI and FGD said that they believe that when their community members or fam-
ily knows their HIV status they will devalue them. A few participants felt family members may even laugh at them if
they came to know. For the majority of the PLWH, the fear of stigma makes them travel to other ART centres far
away, from where they stay to get antiretroviral medication.
“Stigma is still high; it is the main reason why PLWH will rather pick their medication from an ART far
away… Some even go as far as Kumasi because of the stigma” (33-year-old female IDI participant).
Although quite a few participants mentioned real stigma experiences, it appears that the majority of PLWH have
not experienced public stigma but have a strong fear it could happen.
3.2.6 | Disclosure vs. non-disclosure
The majority of the participants in IDI and FGD had informed only one person about their HIV-positive diagnosis.
Most PLWH said that people who they disclosed to did not judge them but empathized. PLWH mostly disclosed to
their spouses, parents, or siblings. Reasons for disclosure included trustworthiness of the person, the need for
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financial, or emotional support to regularly come for antiretroviral refills or feeling obliged to disclose because of the
visibility of the infection.
Some reasons ascribed to non-disclosure were a strong fear for the other persons' response (gossip, maltreat-
ment, and abandonment), not needing help and the fact that their health is a personal matter.
“When I was diagnosed with HIV, I was not worried about my diagnosis; I was rather worried about how
my wife will maltreat me and how unhappy she will make me if she came to know”. (34-year-old male
FGD participant)
To avoid stigma or disclosure, some PLWH resorted to disguising the medication bottles, hiding the antiretrovi-
ral, or denying or lying about their HIV status.
3.2.7 | Fear of recognition at ART clinic
PLWH in both IDI and FGD were afraid to be identified as HIV patients when visiting the clinic for fear of gossip.
This fear influences clinic attendance, hence pill refill and antiretroviral adherence.
“As for the location, hmm it is difficult especially when you start off from the hospital entrance. The
moment you start coming towards the facility everyone knows what is wrong with you”. (24-year-old
female IDI participant)
3.2.8 | Role of religion
Both IDI and FGD participants positively reappraised their purposes in life post-HIV-positive diagnosis because they
believe in God and ART. While others believe that they are still alive by the Grace of God, others depend on their
relationship with God to ignore stigmatizing attitudes of other people. Some PLWH also believed that HIV is from a
deity as such they are predestined to have HIV. PLWH believes that ART is efficacious because God allowed it.
“…I think everything is by God. All you need is to cast all your burdens on God. If I look at the medication,
without God it will never work. I look up to God alone. God is my only hope. No man can help me but only
God”. (30-year-old female IDI participant)
3.2.9 | Coping with HIV
Most PLWH in IDI who accepted their HIV-positive status focused on how to deal with it. Some PLWH compared
HIV to other chronic conditions like hypertension and diabetes and took solace in the fact that living with HIV is
more manageable than hypertension and diabetes.
“….Any illness can kill someone. If you have HIV and you take your medication, it is better than having dia-
betes. I think diabetes is more dangerous than HIV” (36-year-old female IDI participant)
They mentioned that with antiretroviral, PLWH could live their lives to the fullest without any problems; they
can have children who are HIV negative and very healthy despite their HIV positive status. For others, knowing that
they are not the only ones living with HIV makes them accept their condition.
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3.3 | Environmental factors
3.3.1 | Response and support from family and friends
Although most participants indicated that the person to whom they disclosed was sympathetic, some family mem-
bers who knew their HIV status were unwilling to accept that PLWH tested positive. Some PLWH were not allowed
to cook or share their food with any other person. While the relationship of some family members of PLWH remains
unchanged, FGD participants mostly recounted unpleasant experiences such as insults, abandonment, and divorce.
“Honestly, when I came to know I was infected (HIV) I went through a lot, my marriage was broken, and I
was disgraced” (33-year-old female IDI participant)
The support that participants receive from partners, family, or friends varied from financial support, help with
collecting medication and receiving food to receiving reminders for medication intake and advice and real emotional
support, care, and encouragements. Support seemed mostly financial. Some participants described the support they
received from partners and family members as empathic, loving, trusting, and caring.
“Ooh because he [husband] knows [I am HIV positive] he does not disturb me. He takes very good care of
us and supports me with my medication intake”. (30-year-old IDI participant)
However, quite a few also seemed to be just satisfied when family or partner is accepting them and when receiv-
ing money or food, while emotional care seemed to be completely lacking.
“[…] he [husband] was accepting and when I need to come for medication, he gives me money for transpor-
tation if he has it […] but my husband was not angry or anything because he tested negative, he believed
that it was a spiritual illness. […] The only thing is that, recently, there was a funeral in my village and an
aunt of mine got a girlfriend for him who stays in Kintampo. That has caused some problems for us. When
we sleep, he does not even want my body to touch his”.
M: Does it mean his support has dwindled?
R: Well, I will say no. He still provides food for us and takes care of the house' (30-year-old female IDI
participant)
Most PLWH stated that financial support (mostly used for transportation to hospital) was not constant as part-
ner or family regularly stated not having money. Some participants stated not receiving any support at all.
3.3.2 | Community responses
Participants in both FGD and IDI indicated that community members respond negatively towards PLWH even if it is
a mere suspicion that they are HIV positive. The suspicion leads to gossiping or insults. However, when PLWH are
looking healthy (because of ART) these responses tend to stop.
“…..I hoped that, when I took the medication, it was going to help me live long. Therefore, I do not joke
about the medication. Some people are now confused, they are not sure whether I am indeed infected or
not…”. (35-year-old female FGD participant).
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PLWH with real stigma experiences indicated that people around them who know their HIV-positive status tend
to avoid them. They described avoidance to include dissociation and exclusion, not touching PLWH or anything that
belongs to them (food, drinks, etc).
3.3.3 | Organization of ART clinics
Despite the integration of the ART clinic with other chronic conditions like diabetes, the location of ART
clinics within the hospital premises poses a chance of recognition and therefore for stigmatization.
Even though most of the younger participants were afraid of being seen, a few older PLWH were not bothered
about recognition, they said this is because people have different reasons for visiting the hospital.
“Even if it is a bother, we are all sick that is why we are at the hospital. You do not know what is wrong
with me. For all you know your reason for coming to the hospital is bigger than mine” (51-year-old female
IDI participant)
Some PLWH opined that holding a clinic for only one day in a week as was practiced in some ART centres did
not only increase the waiting hours but it also coincides with market days which increases the likelihood for meeting
familiar people. Sometimes they travel all the way to the clinic but do not receive a refill because the medication is
out of stock.
3.3.4 | The attitude of health care providers (HCP)
In general, most PLWH were satisfied with the services they received at the ART clinics. They appreciated the ser-
vice and counselling. They stated that the staff was friendly and respectful.
“Ooh, when we come they do not frown. They are very friendly and take good care of us [….]”. (36-year-
old female IDI participant)
However, some participants said HCP rudely treated them because of their HIV status. They described stigma-
tizing experiences such as HCP frowning, unwillingness to help, taking extra precautionary measures especially with
PLWH, rude, unfriendly, and impatient.
“Some nurses are unfriendly and intolerant. When they know you are infected the way they sometimes
respond to you is not the best” (26-year-old female FGD participants)
3.3.5 | Treatment adherence counselling
The majority of the participants received counselling from two weeks up to several months by either an HCP (nurse,
midwife, pharmacist, doctor) or a model of hope. It was, however, not always clear whether the participants received
both the pre-test counselling and the post-counselling. The counselling that most participants remembered was
centred on information on the efficacy of medication, adherence, medication side effects, transmission routes
(including mother to child), and having a healthy diet/lifestyle (including safe sex and positive future perspective).
“Yes, initially I used to worry a lot… However, whenever we come for medication we are counselled that, if we consistently
take our medication HIV will not kill us. We can live our lives to the fullest” (50-year-old female FGD participant).
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The information received also seemed to help in counselling family members. Few participants received the
advice not to disclose, choose a PLWH as a partner in order not to further spread the virus, or to report stigmatiza-
tion. Treatment options that suited the lifestyles of the participants and self-regulation were rarely mentioned.
3.3.6 | Transportation costs
The majority of the participants indicated that unlike previously when an NGO used to support them, the cost of
transportation to the ART clinic was now a challenge for their regular visit to the clinic and they often lack (financial)
support.
“We have challenges with the cost of transportation. That is why we are requesting that we be supported
to be able to do some work so that we can cater for our medication” (40-year old female FGD participant).
4 | DISCUSSION
In this study, the individual and environmental factors that may influence adherence to ART among people
living with HIV (PLWH) in Ghana were explored using IDI and FGD. The findings suggest that self-regulation,
outcome efficacy, medication side effects, knowledge on HIV, stigma, disclosure, coping, partner, family and
community support, the attitude of health care providers, organization of the ART clinics, and transportation
cost may influence ART adherence. Among these factors, the outcome efficacy of ART, anticipated stigma,
the attitude of healthcare providers, and transportation costs to the ART clinic seem to have the strongest
influence.
A very interesting finding was that participants showed a strong intrinsic motivation to continue their ART medi-
cation because of visible improvements in their overall health. Despite reporting some side effects, mostly during
antiretroviral initiation, the positive outcome of taking ART strongly supported intake. To our knowledge, this strong
impact of visible treatment outcome on ART adherence has not yet been reported in the literature. However, evi-
dence suggests that outcome expectations do indeed influence treatment adherence in patients with various other
medical conditions (Laferton, Kube, Salzmann, Auer, & Shedden-Mora, 2017). We argue that the fast and visible
improvement in our sample influenced their motivation to take their medication. This underscores the need to
develop adherence-counselling models that reiterate PLWH expectation of an efficacious outcome by assessing and
understanding these expectations to optimize treatment outcomes.
Another striking finding was the positive relationship between PLWH and the ART Health Care Provider (HCP).
Most PLWH described HCP as being friendly, supportive, respectful and helpful. They felt healthcare providers lis-
tened to them and did not report any experiences with insults. This finding is in contrast with the majority of the lit-
erature that reports strong stigmatizing responses from HCP to PLWH (Madeleine, Chan, & Thayala, 2011). Our
study adds to the limited data on the positive attitude of HCP towards PLWH (Dapaah, 2016). An explanation for
the positive relationship that we found among HCP as compared to other studies may be that we focused specifi-
cally on HCP working in ART centres while most publications focus on HCP in a broader, general health care sector.
The contact hypothesis may be an explanation that HCP in ART clinics are more empathetic towards PLWH as com-
pared to HCP in the general health care setting (Chan & Tsai, 2017). The difference between HCP in ART centres
verses those in the general health care sector and the role of contact would be worth exploring further as a stigma
reduction strategy.
This notwithstanding, few participants' experienced negative attitudes from the health care providers. In an
attempt to protect themselves from infection, HCP awkwardly interacts with PLWH or treat them differently as
supported by (among others) (Stutterheim et al., 2014). On the other hand, PLWH may have an expectation of
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stereotypic behaviours from HCP and interpretation of HCP behaviour, which may not be necessarily entrenched in
actual prejudice or undesirable attitudes towards PLWH. In their discussion of HIV-related avoidance attitudes
among health care providers in China, Li et al. (2007) assert that HCP's negative attitudes towards PLWH may be
due to fatigue, emotional distresses or work-related stress rather than stigma. We are not suggesting that stigmatiza-
tion is not happening in health care facilities, but we argue that the expectation of stereotypic behaviours may also
influence PLWH clinic visits, hence their medication adherence.
Narratives from PLWH show that they used emotion-focused coping (e.g., religious coping) and problem-
focused coping (e.g., selective disclosure) to deal with stigma and improve medication adherence. A very interesting
finding was that PLWH in this study downplays their seropositive status by comparing it with hypertension and dia-
betes as a way of coping. For example, PLWH tells themselves that hypertension or diabetes is more dangerous than
HIV, and missing a dose in the case of the former will lead to a medical emergency.
Literature suggests that people who find positive meaning to their illness can mentally adjust to the disease
(Farber, Mirsalimi, Williams, & McDaniel, 2003). Attaching a positive meaning to HIV may be beneficial on the psy-
chological adjustment of PLWH. We would contend that the fact that participants mentally adjusted to their HIV sta-
tus by comparing HIV to other chronic conditions shows the resilience of PLWH to live positively with HIV. This
may be beneficial on the psychological well-being of PLWH and may elicit protective health behaviour like adher-
ence to medication.
Interestingly, the accounts of most participants conveyed that only a few of them had experienced enacted
stigma. The majority of the participants merely seem to anticipate stigma, which is one of the main reasons they fear
to visit a nearby ART clinic and were prepared to travel long distances at extra cost for antiretroviral refills. This find-
ing is corroborated by some studies that reported that anticipation of stigma influenced PLWH adherence to ART
(Camacho, Kalichman, & Katner, 2020). Indeed, PLWH is aware of being discriminated against in their social interac-
tions because of which PLWH anticipates stigma (Bos et al., 2013). This anticipation influences adherence to medica-
tion in that PLWH may have to access and take the medication in secrecy with its consequent challenges. Multi-
component interventions that support PLWH to deal with anticipated stigma and engage community agents who are
sources of stigma will be useful for PLWH medication adherence.
Even though ART in Ghana is free of cost to PLWH, results indicate that transportation costs were a barrier for
a clinic visit for an antiretroviral refill and hence adherence. Tuller et al. (2010) reported similar findings that even
though patients had a high level of commitment to adhering to their medication, the high cost of transportation com-
promised adherence to ART and access to care. Supporting PLWH with jobs will enhance the affordability of
services.
PLWH in our study showed that religion is an important form of coping. The importance of religion in HIV stems
from the fact that PLWH receives comfort, care and relief by praying, depending on God to heal or help them to
cope with HIV. When PLWH believes that God grants knowledge to humans to provide medicines for their relief, it
motivates them in adhering to antiretroviral. Religious organizations are important social networks that have the
potential to support or stigmatize PLWH, encourage or hamper HIV education, make PLWH accept or refuse antire-
troviral treatments. As such in Ghana and elsewhere, religious leaders are important stakeholders in HIV manage-
ment support (Nyblade et al., 2003).
However, religion can also negatively influence PLWH by motivating them to stop medication intake and
depend solely on their belief in a cure from HIV (Kretchy et al., 2013). Wanyama and colleagues in their discussions
of ARV adherence in Uganda indicated that about 1% of patients discontinued medication because they believe in
spiritual healing. This treatment interruption not only resulted in treatment failure but also a transition to second line
more expensive options (Wanyama et al., 2007). Few participants perceived HIV was either a spiritual condition, air-
borne, foodborne, or a gift from God. Religious leaders who are engaged as stakeholders in HIV care and support
would benefit from tailored training on how to contribute to PLWH treatment adherence and well-being. The super-
stitious beliefs and myths about HIV and antiretroviral will need to be addressed to improve adherence to
medication.
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PLWH disclosed their HIV status only to people they trust to support them when they need help. The findings
suggest that any form of support is useful in living with HIV and medication intake. However, PLWH who enjoys a
partner's or close family members' support may receive emotional care, which is especially important for patient
medication adherence and well-being (Cohen & Wills, 1985). This is, however, lacking because most of our partici-
pants were not in stable relationships. The lack of support may be influenced by cognitive representations among
the patients' relatives such as perceived responsibility, perceived severity, perceived dangerousness, and perceived
norm-violating behaviour (Bos et al., 2013). Family interventions to reduce these representations may help in
increasing emotional care.
The current study has some limitations. Mostly adherent PLWH may have been included in our sample; we
envisage that their responses could be different from PLWH who do not often come for refills. Also, the majority of
our participants were females, this, however, is reflected in the total number of persons in HIV care in Ghana (Ghana
AIDS Commission, 2020). This could in part be due to the prevention from mother to child transmission (PMCT) pro-
gram and in part due to non-disclosure by females to male partners. Our study recognizes that policies and punitive
laws may be a barrier to ART clinic visits and medication adherence (Laar & Debruin, 2017). This is, however, beyond
the scope of this study. Future research should explore how policy influences PLWH antiretroviral adherence.
This study looked at both individual and environmental factors using qualitative interviews. This allowed for in-
depth knowledge on the context-specific factors that influencing ART adherence. Although PLWH appreciates the
need to adhere to antiretroviral, they face practical challenges. This study identified factors influencing ART adher-
ence that could be used to develop interventions. We suggest the intervention-mapping approach (Bartholomew,
Parcel, & Kok, 1998) to be used to develop, implement and evaluate interventions. These interventions may target
PLWH, partners, families, and health care providers as change agents within the community to improve PLWH
adherence behaviour.
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